Ben Jenkins
About Ben Jenkins
Ben Jenkins is a Principal Biostatistician at Adaptimmune, specializing in oncology and contributing to clinical trials. He has a strong background in both academic and industry settings, with experience in large pharmaceutical organizations.
Work at Adaptimmune
Ben Jenkins has been serving as a Principal Biostatistician at Adaptimmune since 2023. In this role, he focuses on oncology-related biostatistics, contributing to the design and analysis of clinical trials. His work is essential in advancing the company's research initiatives in the biotech sector.
Education and Expertise
Ben Jenkins holds a BSc in Mathematics and Statistics from the University of Warwick, earned between 2014 and 2017. He furthered his education with an MSc in Statistics from Lancaster University, completed in 2018. His academic background supports his specialization in oncology within biostatistics, enhancing his capabilities in both academic and industry settings.
Background
Ben Jenkins has a diverse professional background in biostatistics, having worked in various roles across multiple organizations. He began his career at The Speech House Hotel and later served as a Course Representative at the University of Warwick. His experience includes positions at The Institute of Cancer Research and GSK, where he developed his expertise in clinical trials and statistical analysis.
Achievements
Throughout his career, Ben Jenkins has contributed to significant projects in the field of oncology. His roles as a Medical Statistician at The Institute of Cancer Research and as a Contract Statistician at GSK demonstrate his commitment to advancing biostatistics in clinical research. His work has been instrumental in enhancing the understanding of cancer treatments through statistical methodologies.